Cardiovascular diseases (CVDs) are a major healthcare burden on the population
worldwide. Early detection of this disease is important in prevention and treatment to …

The assessment of chest pain patients presenting to the emergency area (EA) is still a
clinical challenge, as the majority of patients are not diagnosed with acute coronary …

Suspected acute myocardial infarction is one of the leading causes of admission to
emergency departments. In the last decade, biomarkers revolutionized the management of …

Objective: To observe the changes of serum heart-type fatty acid–binding protein (h-FABP)
and brain natriuretic peptide (BNP) in children with chronic heart failure (CHF) and evaluate …

Background The early diagnosis of acute myocardial infarction (AMI) very soon after
symptom onset remains a major clinical challenge, even when using high-sensitivity cardiac …

Suspected acute coronary syndrome (ACS) represents a substantial healthcare problem
and is responsible for a large proportion of emergency department admissions. Better …

Introduction Heart-type fatty acid binding protein (HT FABP) is an emerging biomarker of
ischaemic myocardial necrosis. While previous studies have demonstrated its additive value …

Background Heart-type fatty acid-binding protein (H-FABP) is an early biomarker of cardiac
injury. Randox Laboratories developed an immunoturbidimetric H-FABP assay for non …